GNH USA

Europe — EMA

Paclitaxel Accord Healthcare Ireland

Paclitaxel, the active ingredient in Paclitaxel Accord Healthcare Ireland, is a taxane chemotherapy agent presented as a sterile powder for intravenous infusion use.

Request sourcing

1
Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Accord Healthcare Ireland, is a taxane chemotherapy agent presented as a sterile powder for intravenous infusion use. It treats various solid tumours and is administered under the supervision of oncology specialists.

GNH USA supplies Paclitaxel Accord Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Paclitaxel used for?

Paclitaxel is a chemotherapy drug that interferes ​     ​  ​  ​  ​  ​  ​  ​  ​  ​  ​   ​   ​  ​ ​  ​    ​     ​     ​  - Breast cancer: improves          ​     ​        ​   ​        ​  im  ​  ​   ​ - Ovarian cancer: helps    ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ - Non‑small cell lung cancer: contributes to tumour shrinkage and disease control.

What are the side effects of Paclitaxel?

The          …  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Paclitaxel
Route
Intravenous Use
Manufacturer
Accord Healthcare Ireland Limited
Origin
EU

Related products